John Moschello
Internal Medicine · Thomaston, CTNPI 1073592978
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 520 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 12.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $2,117 and has fallen 91.5% since, to $180 in 2024. Among internal medicine clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 520 payments — averaging $16.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Amarin Pharma, Inc.$1K
- Boehringer Ingelheim$858
- Bayer$707
- AbbVie$629
- Pfizer$536
- plus $4K from 23 others
What the payments were for
- Food & beverage$8,721100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 90 | $1,075 |
| Amarin Pharma, Inc. | 63 | $1,018 |
| Boehringer Ingelheim | 40 | $858 |
| Bayer | 33 | $707 |
| AbbVie(2 entities) | 36 | $629 |
| Pfizer | 28 | $536 |
| Amgen | 29 | $509 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $506 |
| Lilly USA, LLC | 24 | $420 |
| AstraZeneca | 23 | $381 |
| GSK | 18 | $380 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 27 | $363 |
| Johnson & Johnson | 23 | $347 |
| Merck | 16 | $239 |
| Eisai Inc. | 8 | $170 |
| Arbor Pharmaceuticals, Inc. | 7 | $106 |
| Astellas Pharma US Inc | 5 | $86 |
| Kowa Pharmaceuticals America, Inc. | 5 | $82 |
| Genentech USA, Inc. | 4 | $59 |
| Medtronic | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Novartis | 2 | $36 |
| Esperion Therapeutics, Inc. | 1 | $26 |
| Almatica Pharma LLC | 1 | $21 |
| Exact Sciences | 1 | $21 |
| Abbott | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Radius Health, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,733 in reported general payments places this provider in the 90th percentile of 2,067 internal medicine providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 40 | $32,146 |
| JanuviaSitagliptin Phosphate | 26 | $30,196 |
| SynthroidLevothyroxine Sodium | 16 | $1,401 |
| Memantine Hcl ErMemantine Hcl | 13 | $1,114 |
| Atorvastatin Calcium | 76 | $911 |
| Fluoxetine Hcl | 36 | $837 |
| Divalproex Sodium | 11 | $798 |
| Lidocaine | 11 | $768 |
| Levothyroxine Sodium | 62 | $710 |
| Metoprolol Succinate | 33 | $694 |
| Pantoprazole Sodium | 39 | $601 |
| ClopidogrelClopidogrel Bisulfate | 23 | $568 |
| Amlodipine Besylate | 69 | $534 |
| Donepezil Hcl | 25 | $523 |
| Omeprazole | 24 | $509 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $858 | $32,14640 claims |
| MerckJanuvia | $239 | $30,19626 claims |
| AbbVieSynthroid | $629 | $1,40116 claims |
| Almatica Pharma LLCSertraline Hcl | $21 | $35635 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,067 internal medicine providers in Connecticut.
Other internal medicine in Thomaston
- Steven RyderWestport$3.9M
- Nancy BrownNew Haven$1.6M
- Arthur DecillisMadison$1M
- Charles MontanoCromwell$970K
- Gary BlickNorwalk$683K
- Scott GottliebStamford$508K
- Jeffrey KatzOxford$361K
- Nicholas DainiakBridgeport$352K
- Thomas PellechiGreenwich$196K
- John PriceGlastonbury$188K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.